Literature DB >> 22346250

Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease.

Lars-Petter Jelsness-Jørgensen1, Tomm Bernklev, Magne Henriksen, Roald Torp, Bjørn Moum.   

Abstract

AIM: To investigate the impact of chronic fatigue on disease-related worries in inflammatory bowel disease (IBD) and the potential multicolinearity between subjective questionnaires.
METHODS: Patients in remission or with mild-to-moderate disease activity completed the fatigue questionnaire (FQ), the rating form of IBD patient concerns (RFIPC), the Short-Form 36 (SF-36), and IBD questionnaire (N-IBDQ). In addition, clinical and epidemiological data were obtained.
RESULTS: In total, 140 patients were included; of which 92 were diagnosed with ulcerative colitis and 48 with Crohn's disease. The mean age of patients with chronic fatigue was 44.2 years (SD = 15.8) and for non-fatigued patients was 44.7 years (SD = 16.0). Chronic fatigued patients had clinically significantly increased levels of disease-related worries, as measured by Cohen's d effect size. Worries about having an ostomy bag, loss of bowel control, and energy levels were most prominent in both chronic fatigued and non-chronic fatigued IBD patients. Variance inflation factor (VIF) and tolerance indicated that there were no problematic multicolinearity among the FQ, RFIPC, SF-36 and N-IBDQ responses (VIF < 5 and tolerance > 2).
CONCLUSION: Chronic fatigue is associated with increased levels of disease-related worries and concerns in IBD. Increased levels of worries were also associated with impaired health-related quality of life.

Entities:  

Keywords:  Fatigue; Health-related quality of life; Inflammatory bowel disease; Patient reported outcome; Worries

Mesh:

Year:  2012        PMID: 22346250      PMCID: PMC3270510          DOI: 10.3748/wjg.v18.i5.445

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Concerns of patients with inflammatory bowel disease: results from a clinical population.

Authors:  E C de Rooy; B B Toner; R G Maunder; G R Greenberg; D Baron; A H Steinhart; R McLeod; Z Cohen
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

2.  A theoretical extension of the concept of energy through an empirical study.

Authors:  Anners Lerdal
Journal:  Scand J Caring Sci       Date:  2002-06

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls.

Authors:  Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Magne Henriksen; Roald Torp; Bjørn A Moum
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

5.  Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ.

Authors:  T Bernklev; B Moum; T Moum
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

6.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

Review 7.  Fatigue in chronic disease.

Authors:  M G Swain
Journal:  Clin Sci (Lond)       Date:  2000-07       Impact factor: 6.124

8.  Providing disease-related information worsens health-related quality of life in inflammatory bowel disease.

Authors:  Mark R Borgaonkar; Gillian Townson; Marysia Donnelly; E Jan Irvine
Journal:  Inflamm Bowel Dis       Date:  2002-07       Impact factor: 5.325

9.  The rating form of IBD patient concerns: a new measure of health status.

Authors:  D A Drossman; J Leserman; Z M Li; C M Mitchell; E A Zagami; D L Patrick
Journal:  Psychosom Med       Date:  1991 Nov-Dec       Impact factor: 4.312

10.  A new measure of health status for clinical trials in inflammatory bowel disease.

Authors:  G Guyatt; A Mitchell; E J Irvine; J Singer; N Williams; R Goodacre; C Tompkins
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

View more
  14 in total

1.  Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients.

Authors:  Yan-Cheng Dai; Ya-Li Zhang; Li-Juan Wang; Qian Guo; Kun Yang; Ren-Hao Ye; Zhi-Peng Tang
Journal:  Chin J Integr Med       Date:  2015-10-26       Impact factor: 1.978

Review 2.  Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review.

Authors:  Aaron Yarlas; Martha Bayliss; Joseph C Cappelleri; Stephen Maher; Andrew G Bushmakin; Lea Ann Chen; Alireza Manuchehri; Paul Healey
Journal:  Qual Life Res       Date:  2017-08-28       Impact factor: 4.147

Review 3.  Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Authors:  Tiffany H Taft; Sarah Ballou; Alyse Bedell; Devin Lincenberg
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

4.  Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue.

Authors:  Lars-Petter Jelsness-Jørgensen; Svein-Oskar Frigstad; Bjørn Moum; Tore Grimstad; Randi Opheim; Jørgen Jahnsen; Tomm Bernklev
Journal:  United European Gastroenterol J       Date:  2016-10-06       Impact factor: 4.623

5.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

Review 6.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

7.  Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey.

Authors:  Laura Marín; Míriam Mañosa; Esther Garcia-Planella; Jordi Gordillo; Yamile Zabana; Eduard Cabré; Eugeni Domènech
Journal:  J Gastroenterol       Date:  2012-11-03       Impact factor: 7.527

8.  Depression subtypes in pediatric inflammatory bowel disease.

Authors:  Eva M Szigethy; Ada O Youk; David Benhayon; Diane L Fairclough; Melissa C Newara; Margaret A Kirshner; Simona I Bujoreanu; Christine Mrakotsky; Athos Bousvaros; Arvind I Srinath; David J Keljo; David J Kupfer; David R DeMaso
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-05       Impact factor: 2.839

9.  Fatigue interference with daily living among patients with inflammatory bowel disease.

Authors:  Randi Opheim; May Solveig Fagermoen; Tomm Bernklev; Lars-Petter Jelsness-Jorgensen; Bjorn Moum
Journal:  Qual Life Res       Date:  2013-08-23       Impact factor: 4.147

10.  Interventions for fatigue in inflammatory bowel disease.

Authors:  Dawn Farrell; Micol Artom; Wladyslawa Czuber-Dochan; Lars P Jelsness-Jørgensen; Christine Norton; Eileen Savage
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.